Entera Bio Ltd. (ENTX)
Automate Your Wheel Strategy on ENTX
With Tiblio's Option Bot, you can configure your own wheel strategy including ENTX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
Published: December 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections
Read More
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Published: November 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference, details as below.
Read More
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.
Read More
About Entera Bio Ltd. (ENTX)
- IPO Date 2018-06-28
- Website https://www.enterabio.com
- Industry Biotechnology
- CEO Miranda J. Toledano
- Employees 18